Market Research Logo

Global Contraceptive Market: Size, Trends and Forecasts (2018-2022)

Scope of the Report

The report titled “Global Contraceptive Market: Size, Trends and Forecasts (2018-2022)”, provides an in depth analysis of the global contraceptive market by value, by segments, by region, etc. The report also provides a regional analysis of the contraceptive market, including the following regions: North America (the US & Canada), Europe (UK, Germany and Rest of Europe), Asia pacific and ROW.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global contraceptive market has also been forecasted for the period 2018-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The global contraceptive market is highly fragmented with many contraceptive market players operating worldwide. Some contraceptive market players operating on a local level while other contraceptive players operating on a regional and global level. The manufacturers of contraceptive market produce different type of contraceptives, some manufacturers produce contraceptive drugs, some produce contraceptive devices while other produce both contraceptive drugs and devices.

However, the competition in the global contraceptive market is dominated by few contraceptive manufacturers. Further, key players of the contraceptive market are Pfizer, Inc., Bayer AG, Merck & Co, Inc., Allergan Plc. are also profiled with their financial information and respective business strategies.

Country Coverage

North America
Europe
Asia Pacific
ROW

Company Coverage

Pfizer, Inc.
Bayer AG
Merck & Co., Inc.
Allergan Plc.

Executive Summary

Contraception, also referred as birth control, is a method to prevent unwanted pregnancy by restraining with the normal process of fertilization with the help of drugs, barriers, devices and surgical techniques. Contraceptives are the drugs or devices which inhibit unintended pregnancy as well as Sexually Transmitted Diseases (STDs), such as chlamydia, gonorrhea, HIV/AIDS, syphilis, etc. There are various forms of contraceptives available that can be used at different times in the process. Unfortunately, there is no perfect form of contraceptive. There is a failure rate associated with the use of each and every contraceptive.

The benefits of using contraceptive are reduction in pregnancy-related risk, reduction in teenage pregnancies, population control, low risk of sexually transmitted infection, etc. The common side effects associated with the use of contraception are vomiting, weight gain, bleeding between periods or spotting, nausea, breast swelling, urinary tract infection (UTIs), allergies, etc.

Contraceptives have a long history with continuous adoption of effective contraceptives to prevent pregnancy and a shift from traditional contraceptives to modern contraceptives. Presently, contraceptive devices are used by approximately 100 million women across the globe. The contraceptive market can be segmented on the basis of product type and end-user.

The global contraceptive market has increased significantly during the years 2015-2017 and projections are made that the market would rise in the next four years i.e. 2018-2022 tremendously. The contraceptive market is expected to increase due to growing urban population, declining fertility rate, rising number of women at risk for pregnancy, increasing number of women in workforce, surging population with secondary education, etc. Yet the market faces some challenges such as, side effects associated with the contraceptive drugs and devices, lack of social acceptance, less use of contraception among the poor women, etc.


1. Executive Summary
2. Introduction
2.1 Contraceptive: An Overview
2.1.1 Different Ways to Use Contraceptive Methods
Table 1: Different Ways to Use Contraceptive Methods
2.1.2 History of Contraceptives
Table 2: History of Contraceptives
2.1.3 Benefits of Contraception Use
Table 3: Benefits of Contraception Use
2.1.4 Contraception: Types and Side Effects
Table 4: Contraception: Types and Side Effects
2.2 Contraceptive Segmentation: An Overview
2.2.1 Contraceptive Segmentation by Product Type
Table 5: Contraceptive Segmentation by Product Type
2.2.2 Contraceptive Segmentation by End-user
Table 6: Contraceptive Segmentation by End-user
3. Global Market Analysis
3.1 Global Contraceptive Market: An Analysis
3.1.1 Global Contraceptive Market by Value
Table 7: Global Contraceptive Market by Value; 2015-2017 (US$ Billion)
Table 8: Global Contraceptive Market by Value; 2018-2022 (US$ Billion)
3.1.2 Global Contraceptive Market by Segments (Contraceptive Devices and Contraceptive Drugs)
Table 9: Global Contraceptive Market by Segments; 2017 (Percentage, %)
3.1.3 Global Contraceptive Market by Region (North America, Europe, Asia Pacific and ROW)
Table 10: Global Contraceptive Market by Region; 2017 (Percentage, %)
3.2 Global Contraceptive Market: Segment Analysis
3.2.1 Global Contraceptive Drugs Market by Value
Table 11: Global Contraceptive Drugs Market by Value; 2015-2017 (US$ Billion)
Table 12: Global Contraceptive Drugs Market by Value; 2018-2022 (US$ Billion)
3.2.2 Global Contraceptive Devices Market by Value
Table 13: Global Contraceptive Devices Market by Value; 2015-2017 (US$ Billion)
Table 14: Global Contraceptive Devices Market by Value; 2018-2022 (US$ Billion)
4. Regional Market Analysis
4.1 North America Contraceptive Market: An Analysis
4.1.1 North America Contraceptive Market by Value
Table 15: North America Contraceptive Market by Value; 2015-2017 (US$ Billion)
Table 16: North America Contraceptive Market by Value; 2018-2022 (US$ Billion)
4.1.2 North America Contraceptive Market by Region (The US and Canada)
Table 17: North America Contraceptive Market by Region; 2017 (Percentage, %)
4.2 North America Contraceptive Market: Regional Analysis
4.2.1 The US Contraceptive Market by Value
Table 18: The US Contraceptive Market by Value; 2015-2017 (US$ Billion)
Table 19: The US Contraceptive Market by Value; 2018-2022 (US$ Billion)
4.2.2 The US Contraceptive Market by Segments (Hormonal and Non-hormonal)
Table 20: The US Contraceptive Market by Segments; 2017 (Percentage, %)
4.2.3 The US Hormonal Contraceptive Market by Value
Table 21: The US Hormonal Contraceptive Market by Value; 2015-2017 (US$ Billion)
Table 22: The US Hormonal Contraceptive Market by Value; 2018-2022 (US$ Billion)
4.2.4 The US Hormonal Contraceptive Market by Segments (Oral Contraceptive, Hormonal IUD (Intrauterine Device), Injectable, Vaginal Ring, Implants and Patch)
Table 23: The US Hormonal Contraceptive Market by Segments; 2017 (Percentage, %)
4.2.5 The US Oral Contraceptive Market by Value
Table 24: The US Oral Contraceptive Market by Value; 2015-2017 (US$ Billion)
Table 25: The US Oral Contraceptive Market by Value; 2018-2022 (US$ Billion)
4.2.6 The US Hormonal IUD Contraceptive Market by Value
Table 26: The US Hormonal IUD Contraceptive Market by Value; 2015-2017 (US$ Billion)
Table 27: The US Hormonal IUD Contraceptive Market by Value; 2018-2022 (US$ Billion)
4.2.7 The US Injectable Contraceptive Market by Value
Table 28: The US Injectable Contraceptive Market by Value; 2015-2017 (US$ Million)
Table 29: The US Injectable Contraceptive Market by Value; 2018-2022 (US$ Million)
4.2.8 The US Vaginal Ring Contraceptive Market by Value
Table 30: The US Vaginal Ring Contraceptive Market by Value; 2015-2017 (US$ Million)
Table 31: The US Vaginal Ring Contraceptive Market by Value; 2018-2022 (US$ Million)
4.2.9 The US Implants Contraceptive Market by Value
Table 32: The US Implants Contraceptive Market by Value; 2015-2017 (US$ Million)
Table 33: The US Implants Contraceptive Market by Value; 2018-2022 (US$ Million)
4.2.10 The US Patch Contraceptive Market by Value
Table 34: The US Patch Contraceptive Market by Value; 2015-2017 (US$ Million)
Table 35: The US Patch Contraceptive Market by Value; 2018-2022 (US$ Million)
4.2.11 The US Non-Hormonal Contraceptive Market by Value
Table 36: The US Non-Hormonal Contraceptive Market by Value; 2015-2017 (US$ Billion)
Table 37: The US Non-Hormonal Contraceptive Market by Value; 2018-2022 (US$ Billion)
4.2.12 Canada Contraceptive Market by Value
Table 38: Canada Contraceptive Market by Value; 2015-2017 (US$ Billion)
Table 39: Canada Contraceptive Market by Value; 2018-2022 (US$ Billion)
4.3 Europe Contraceptive Market: An Analysis
4.3.1 Europe Contraceptive Market by Value
Table 40: Europe Contraceptive Market by Value; 2015-2017 (US$ Billion)
Table 41: Europe Contraceptive Market by Value; 2018-2022 (US$ Billion)
4.3.2 Europe Contraceptive Market by Region (Germany, UK and Rest of Europe)
Table 42: Europe Contraceptive Market by Region; 2017 (Percentage, %)
4.4 Europe Contraceptive Market: Regional Analysis
4.4.1 UK Contraceptive Market by Value
Table 43: UK Contraceptive Market by Value; 2015-2017 (US$ Billion)
Table 44: UK Contraceptive Market by Value; 2018-2022 (US$ Billion)
4.4.2 Germany Contraceptive Market by Value
Table 45: Germany Contraceptive Market by Value; 2015-2017 (US$ Billion)
Table 46: Germany Contraceptive Market by Value; 2018-2022 (US$ Billion)
4.4.3 Germany Contraceptive Market by Segments (Oral Contraceptive Pills, Injectable Contraceptives and Topical Contraceptives)
Table 47: Germany Contraceptive Market by Segments; 2017 (Percentage, %)
4.4.4 Germany Oral Contraceptive Pills Market by Value
Table 48: Germany Oral Contraceptive Pills Market by Value; 2015-2017 (US$ Billion)
Table 49: Germany Oral Contraceptive Pills Market by Value; 2018-2022 (US$ Billion)
4.4.5 Germany Injectable Contraceptive Market by Value
Table 50: Germany Injectable Contraceptive Market by Value; 2015-2017 (US$ Million)
Table 51: Germany Injectable Contraceptive Market by Value; 2018-2022 (US$ Million)
4.4.6 Germany Topical Contraceptive Market by Value
Table 52: Germany Topical Contraceptive Market by Value; 2015-2017 (US$ Million)
Table 53: Germany Topical Contraceptive Market by Value; 2018-2022 (US$ Million)
4.4.7 Rest of Europe Contraceptive Market by Value
Table 54: Rest of Europe Contraceptive Market by Value; 2015-2017 (US$ Billion)
Table 55: Rest of Europe Contraceptive Market by Value; 2018-2022 (US$ Billion)
4.5 Asia Pacific Contraceptive Market: An Analysis
4.5.1 Asia Pacific Contraceptive Market by Value
Table 56: Asia Pacific Contraceptive Market by Value; 2015-2017 (US$ Billion)
Table 57: Asia Pacific Contraceptive Market by Value; 2018-2022 (US$ Billion)
4.6 ROW Contraceptive Market: An Analysis
4.6.1 ROW Contraceptive Market by Value
Table 58: ROW Contraceptive Market by Value; 2015-2017 (US$ Billion)
Table 59: ROW Contraceptive Market by Value; 2018-2022 (US$ Billion)
5. Market Dynamics
5.1 Growth Driver
5.1.1 Growing Urban Population
Table 60: Global Urban Population by Region; 2013-2017 (Million)
5.1.2 Declining Fertility Rate
Table 61: Global Fertility Rate; 2009-2016 (Births per Woman)
Table 62: Global Adolescent Fertility Rate; 2009-2016 (Births per 1000 women)
5.1.3 Rising Number of Women at Risk for Pregnancy
Table 63: The US Women at Risk for Pregnancy; 2017-2022 (Million)
5.1.4 Falling Prevalence of HIV/AIDS Infection
Table 64: The US Diagnosis of HIV/AIDS Infection; 2011-2016 (Million)
5.1.5 Increasing Number of Women in Workforce
Table 65: Number of Women in Workforce Worldwide by Age; 2012-2017 (Million)
5.1.6 Surging Population with Secondary Education
Table 66: Female Population Attained Atleast Secondary Education by Region; 2013-2017 (Percentage, %)
Table 67: Male Population Attained Atleast Secondary Education by Region; 2013-2017 (Percentage, %)
5.2 Challenges
5.2.1 Side Effects Associated with the Use of Contraceptive Drugs and Devices
5.2.2 Lack of Social Acceptance
5.2.3 Less Use of Contraception among the Poor Women
5.3 Market Trends
5.3.1 Increasing Adoption Rate of Contraceptive
Table 68: Contraceptive Use by region; 1994-2017 (Percentage, %)
5.3.2 Contraceptive Program/Methods in Development
Table 69: Contraceptive Program/Methods in Development
5.3.3 Rising Public Awareness and Changing Lifestyle
5.3.4 Easy Availability of Modern Contraceptive
6. Competitive Landscape
6.1 Global Contraceptive Market Players: A Financial Comparison
Table 70: Global Contraceptive Market Players: A Financial Comparison; 2017
6.2 Global Contraceptive Market Players by Programs in Development
Table 71: Global Contraceptive Market Players by Programs in Development
7. Company Profiles
7.1 Pfizer, Inc.
7.1.1 Business Overview
7.1.2 Financial Overview
Table 72: Pfizer, Inc. Revenue; 2013-2017 (US$ Billion)
Table 73: Pfizer, Inc. Revenue by Segments; 2017 (Percentage, %)
Table 74: Pfizer, Inc. Revenue by Region; 2017 (Percentage, %)
7.1.3 Business Strategy
7.2 Bayer AG
7.2.1 Business Overview
7.2.2 Financial Overview
Table 75: Bayer AG Sales; 2013-2017 (US$ Billion)
Table 76: Bayer AG Sales by Segments; 2017 (Percentage, %)
Table 77: Bayer AG by Region; 2017 (Percentage, %)
7.2.3 Business Strategy
7.3 Merck & Co., Inc.
7.3.1 Business Overview
7.3.2 Financial Overview
Table 78: Merck & Co., Inc. Sales; 2013-2017 (US$ Billion)
Table 79: Merck & Co., Inc. Sales by Segments; 2017 (Percentage, %)
Table 80: Merck & Co., Inc. Sales by Region; 2017 (Percentage, %)
7.3.3 Business Strategy
7.4 Allergan Plc.
7.4.1 Business Overview
7.4.2 Financial Overview
Table 81: Allergan Plc. Net Revenue; 2013-2017 (US$ Billion)
Table 82: Allergan Plc. Net Revenue by Segments; 2017 (Percentage, %)
7.4.3 Business Strategy

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report